Phenergan claim


Intravenous news: The US Supreme Court ruled Wednesday that pharmaceutical companies can be sued over serious side effects of drugs even when warning labels have been approved by the Federal Drug Administration.

The 6-3 ruling against the drug maker Wyeth opens the door to litigation in thousands of similar cases, lawyers say.

The high court found in favor of Diana Levine, a musician who was awarded 6.7 million dollars in damages by a Vermont court after she developed gangrene and lost her right forearm because of the anti-nausea drug Phenergan.

The court rejected arguments by Wyeth, the drug’s manufacturer, that the Federal Drug Administration had approved warning labels for the drug and that that took precedence over the state law under which the suit was brought.

Click here for the full story.

More IV news at IVTEAM


Comments are closed.